adenosine has been researched along with Chronic Kidney Diseases in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| DE Luca, G; Gioscia, R; Kedhi, E; Nardin, M; Rognoni, A; Suryapranata, H; Verdoia, M | 1 |
| Arthur, JM; Arulprakash, N; Corken, A; Dai, J; Davis, O; Hedayati, SS; Jain, N; Mehta, JL; Phadnis, MA; Rahmatallah, Y; Smyth, S; Ware, J | 1 |
| Ho, MY; Hsieh, IC; Hung, KC; Lin, TA; Tsai, ML; Wang, CY; Wen, MS; Yeh, JK | 1 |
| Dwyer, KM; Kishore, BK; Robson, SC | 1 |
| Chen, J; Huang, H; Li, W; Ouyang, L; Su, X; Tang, L; Xie, C; Zhang, M; Zhang, P; Zhu, Y | 1 |
| Desai, RJ; Gagne, JJ; Mogun, H; Spoendlin, J | 1 |
| Han, Y; Li, C; Li, J; Li, Y; Qi, J; Tang, Y; Wang, H | 1 |
| Faull, R; Gleadle, JM; Selvanayagam, JB; Shah, R; Sree Raman, K; Walls, A; Woodman, RJ | 1 |
| Bouatou, Y; Gabrielli, A; Saudan, P | 1 |
| Abe, T; Akamatsu, Y; Akiyama, Y; Araki, K; Araki, M; Bonventre, JV; Ichimura, T; Imai, Y; Inoue, C; Inoue, R; Ito, K; Ito, S; Itoh, K; Jinno, D; Kawagisihi, N; Masuda, S; Mishima, E; Miyagi, S; Mount, DB; Ohkubo, T; Sabbisetti, V; Saigusa, D; Saiki, Y; Shima, H; Shimizu, R; Shinke, H; Soga, T; Suzuki, C; Suzuki, T; Suzuki, Y; Takeuchi, Y; Tominaga, T; Tomioka, Y; Toyohara, T; Tsukui, Y; Yamamura, K | 1 |
| Alexander, SI; Cowan, PJ; Dwyer, KM; Roberts, VS; Robson, SC | 1 |
| Alessi, MC; Bassez, C; Bonnet, G; Bonnet, JL; Cuisset, T; Deharo, P; Morange, P; Pankert, M; Quilici, J; Verdier, V | 1 |
| Bangalore, S; De Pasquale, CG; Gleadle, JM; Grover, S; Parnham, S; Perry, R; Selvanayagam, JB; Woodman, RJ | 1 |
| Ardissino, D; Aylward, P; Bhatt, DL; Bonaca, MP; Braunwald, E; Cohen, M; Corbalan, R; Dellborg, M; Goudev, AR; Held, P; Im, K; Isaza, D; Jensen, EC; Kontny, F; Kuder, J; Magnani, G; Medina, F; Parkhomenko, A; Sabatine, MS; Steg, G; Storey, RF | 1 |
| Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Suryapranata, H; Verdoia, M | 1 |
| Dégano, IR; Elosua, R; Grau, M; Marrugat, J; Sayols-Baixeras, S | 1 |
| Alarcón, S; Garrido, W; Oyarzún, C; Quezada, C; San Martín, R; Sobrevia, L; Yáñez, A | 1 |
| Fukuda, H; Furuhashi, T; Hase, H; Joki, N; Kunimasa, T; Masai, H; Moroi, M; Sugi, K | 1 |
| Banno, H; Hayashi, M; Inoue, Y; Ishii, H; Isobe, S; Kato, K; Komori, K; Kumagai, S; Matsubara, T; Murohara, T; Ohshima, S; Okumura, S; Suzuki, S; Yoshikawa, D | 1 |
4 review(s) available for adenosine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Topics: 5'-Nucleotidase; Acute Kidney Injury; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Carcinoma, Renal Cell; Diabetic Nephropathies; Graft Rejection; Humans; Immune Tolerance; Inflammation; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Macrophages; Polycystic Kidney Diseases; Receptors, Purinergic P1; Receptors, Purinergic P2; Renal Insufficiency, Chronic; Reperfusion Injury; Signal Transduction; T-Lymphocytes, Regulatory | 2020 |
[Use of antiplatelet agents in patients with chronic kidney disease: what is the evidence?].
Topics: Adenosine; Blood Platelet Disorders; Clopidogrel; Evidence-Based Practice; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Renal Insufficiency, Chronic; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine | 2014 |
The role of adenosine receptors A2A and A2B signaling in renal fibrosis.
Topics: Adenosine; Adenosine Triphosphatases; Animals; Antigens, CD; Apyrase; Autocrine Communication; Fibroblasts; Fibrosis; Humans; Kidney; Macrophages; Paracrine Communication; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Renal Insufficiency, Chronic; Signal Transduction | 2014 |
Adenosine contribution to normal renal physiology and chronic kidney disease.
Topics: Adenosine; Humans; Kidney; Kidney Tubules; Renal Insufficiency, Chronic; Signal Transduction; Vasoconstriction | 2017 |
3 trial(s) available for adenosine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease.
Topics: Adenosine; Clopidogrel; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome | 2023 |
Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Renal Elimination; Renal Insufficiency, Chronic; Ticagrelor; Ticlopidine; Treatment Outcome | 2018 |
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Topics: Adenosine; Aged; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Risk Factors; Ticagrelor; Treatment Outcome | 2016 |
12 other study(ies) available for adenosine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor.
Topics: Acute Coronary Syndrome; Adenosine; Aftercare; Clopidogrel; Humans; Patient Discharge; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Insufficiency; Renal Insufficiency, Chronic; Ticagrelor; Ticlopidine | 2023 |
Regulation of autophagy in leukocytes through RNA N
Topics: Adenosine; Aged; Autophagy; Female; Humans; Leukocytes; Male; Methylation; Middle Aged; Renal Insufficiency, Chronic; RNA | 2020 |
ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.
Topics: Adenosine; Aged; AlkB Homolog 1, Histone H2a Dioxygenase; Animals; Cellular Reprogramming; DNA Methylation; Female; Humans; Male; Mice; Mice, Transgenic; Middle Aged; Osteogenesis; Renal Insufficiency, Chronic; Vascular Calcification | 2021 |
Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease.
Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Cohort Studies; Diabetes Mellitus; Drug Utilization Review; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Ticagrelor; Ticlopidine | 2017 |
Gadolinium-Free Cardiovascular Magnetic Resonance Stress T1 Mapping in Patients With Chronic Kidney Disease.
Topics: Adenosine; Case-Control Studies; Contrast Media; Coronary Artery Disease; Female; Humans; Kidney; Magnetic Resonance Imaging; Male; Myocardium; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Vasodilator Agents | 2019 |
Conformational change in transfer RNA is an early indicator of acute cellular damage.
Topics: Acute Kidney Injury; Adenosine; Aged; Animals; Apoptosis; Case-Control Studies; DNA Damage; Female; Humans; Japan; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Molecular Conformation; Oxidative Stress; Rats, Wistar; Renal Insufficiency, Chronic; RNA, Transfer | 2014 |
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Drug Monitoring; Female; Humans; Kidney Function Tests; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Statistics as Topic; Ticagrelor; Treatment Outcome | 2015 |
Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease.
Topics: Adenosine; Adult; Aged; Biomarkers; Case-Control Studies; Contrast Media; Female; Fibrosis; Glomerular Filtration Rate; Heart Diseases; Humans; Kidney; Kidney Transplantation; Linear Models; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Organometallic Compounds; Oxygen; Oxygen Consumption; Predictive Value of Tests; Renal Insufficiency, Chronic; Vasodilator Agents | 2015 |
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Topics: Adenosine; Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Ticagrelor; Ticlopidine | 2016 |
Prevalence and Prognosis of High-risk Myocardial Infarction Patient Candidates to Extended Antiplatelet Therapy.
Topics: Adenosine; Age Factors; Aged; Aged, 80 and over; Aspirin; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Prevalence; Prognosis; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Assessment; Secondary Prevention; Spain; Ticagrelor; Time Factors | 2016 |
The predictive value of chronic kidney disease for assessing cardiovascular events under consideration of pretest probability for coronary artery disease in patients who underwent stress myocardial perfusion imaging.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Angina, Unstable; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Predictive Value of Tests; Probability; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2013 |
Post-stress perfusion abnormalities detected on myocardial perfusion single-photon emission computed tomography predict long-term mortality after elective abdominal aortic aneurysm repair.
Topics: Adenosine; Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Chi-Square Distribution; Coronary Circulation; Diabetes Complications; Elective Surgical Procedures; Endovascular Procedures; Female; Heart Diseases; Humans; Japan; Kaplan-Meier Estimate; Male; Multivariate Analysis; Myocardial Perfusion Imaging; Predictive Value of Tests; Proportional Hazards Models; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vascular Surgical Procedures; Vasodilator Agents | 2013 |